
Latest stock market news, company updates, and price movements. Stay updated with market trends, earnings insights, and investment analysis.
Infosys has dropped to 12th among India’s most valued listed companies after Adani Power overtook it, underlining the gap between strong power stocks and weak IT.
AM/NS India says it is the first steelmaker to produce ABS-certified EQ70 welded pipes equivalent to API 5L X100, targeting offshore and marine applications.
Nomura reiterated Buy on Alkem and lifted its target, even as investors weigh a loss-making medtech deal, USFDA observations, and recent profit-versus-revenue divergence.
Bharat Dynamics fell over 8% after weak Q4FY26 results, as brokerages flagged execution delays and margin pressure, despite a strong backlog and FY27 order-inflow guidance.
Motor & General Finance reported a sharply higher FY26 profit due to exceptional gains from selling an investment property, while revenue stayed flat and consolidated assets rose.
Brent and WTI slipped after reports of a proposed 60-day US-Iran ceasefire extension that could ease Strait of Hormuz shipping restrictions, even as tensions remain unresolved.
Alkem Laboratories posted 14.6% YoY revenue growth in Q4 FY26 to ₹3,603 crore, but net profit fell to ₹236 crore as margins and costs weighed on results.
Blackstone sold its remaining 20.5% stake in Sona BLW Precision Forgings (Sona Comstar) for Rs 4,917 crore via bulk deals, triggering a sharp one-day stock drop.
Wipro rose up to 4.76% after expanding its ServiceNow partnership to deploy agentic AI workflows across IT, HR, procurement and cybersecurity, lifting broader IT stocks.
Sudarshan Chemical traded near ₹968-₹976 in late May 2026 as brokerages reiterated mixed calls, with targets ranging from ₹780 to ₹1,700 amid Heubach-related margin concerns.
Wipro climbed after expanding its ServiceNow AI partnership, alongside optimism from a $1 billion Olam deal and a ₹15,000 crore buyback, lifting Nifty IT.
A weaker rupee, rising crude-led external pressure, and heavy foreign selling are testing India’s ability to support both the currency and equities at the same time.
Alkem Laboratories reported lower Q4 FY26 profit due to exceptional items and higher tax, but strong revenue and EBITDA growth supported the stock and FY27 pipeline plans.
Supriya Lifescience posted strong FY26 and quarterly revenue growth, improving profits in recent periods, while operating margin pressure and FY27 guidance remain key investor monitorables.
Vedanta shares hit a record high after ICRA upgraded key group entities’ long-term ratings to AA+ and reaffirmed the A1+ short-term rating amid demerger progress.
Ashok Leyland reported 14% YoY Q4 FY26 profit growth and a 17% rise in revenue, but the stock fell 2% amid margin and cost concerns.